Archive for February, 2012

01.02.2012 healthcare, venture capital No Comments

AngioDynamics Acquires Navilyst

AngioDynamics ($ANGO) has agreed to buy rival Navilyst Medical, which focuses on vascular access, interventional radiology and interventional cardiology, in a deal valued at $372 million. The buy is expected to boost AngioDynamic’s vascular access market share, The Post Star notes. The boards of both companies have approved the transaction, which is expected to close by the quarter ending May 31.

read more

01.02.2012 FDA Approved No Comments

2011 FDA Approvals

By Liz Jones Hollis and Jennifer Levin
Welcome to our annual look back at FDA approvals. 2011 was a big year for drugmakers seeking to get their innovative products approved, as the FDA was busy. In fact, the agency approved 30 new drugs last year (a 7-year high). Among the lucky bunch who got an FDA nod were Johnson & Johnson ($JNJ) and GlaxoSmithKline ($GSK), both of which snagged three approvals each.

read more